Creyon Bio logo

Creyon Bio

Delivering RNA breakthroughs. Redefining hope.

31 employees · est. 2019 · San Diego, United States

VS
Expansion Therapeutics logo

Expansion Therapeutics

Bringing transformative therapies to patients with severe RNA-mediated diseases.

29 employees · est. 2016 · Jupiter, United States

Expansion Therapeutics is the older company (2019 vs 2016).

Side-by-Side Comparison

Creyon Bio Expansion Therapeutics
Founded
2019 2016 older
Headquarters
San Diego, United States Jupiter, United States
Employees
31 29
Industry
Biotechnology, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Series A Series Unknown
Total Funding
$40.00M $142.22M
Funding Rounds
1 3
Services
RNA therapy development, Tissue-specific delivery, CNS indication support, Splice-switching oligonucleotide therapy, Nucleic acid therapeutics Not tracked yet
Target Customers
Pharmaceutical companies, Biotech researchers, Healthcare providers, Patients with immune-driven diseases, Patients with CNS and neuromuscular conditions Not tracked yet
Taxonomy
RNA Drug Design, AI-driven Drug Development, Nucleic Acid Therapies, Tissue-specific Delivery, Neuromuscular Disorders, Central Nervous System Disorders, Immunology Disorders, Tissue Biology, Computational Drug Design, Precision Medicine, Machine Learning In Drug Development, Precision Oligonucleotide-based Medicines, Pre-clinical Stage, Patient-centered Therapies, Data-driven Drug Development RNA-mediated Diseases, Drug Discovery, Small Molecule Medicines, Expansion Repeat Diseases, Therapeutics, Jupiter, Florida, Intellectual Property, RNA-targeted Drug Candidates, Potent Small Molecule Binders, Biopharmaceutical, Precision Medicine, Therapeutic Development, Biomedical Research, Drug Development
Website
creyonbio.com expansionrx.com
Creyon Bio logo

About Creyon Bio

Creyon Bio, founded in 2019, is at the forefront of RNA drug design, operating within the Biotechnology and Life Sciences industries. Headquartered in the United States, Creyon aims to transform the therapeutic landscape with its AI-driven approach to crafting tissue-specific, RNA-targeted nucleic a...

Expansion Therapeutics logo

About Expansion Therapeutics

Expansion Therapeutics, founded in 2016, is a biotechnology and healthcare startup based in United States. The company's mission as stated in their slogan, "Bringing transformative therapies to patients with severe RNA-mediated diseases," is to develop small molecule medicines for RNA-mediated disea...

We will tell you when either one moves

BounceWatch watches Creyon Bio and Expansion Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Creyon Bio and Expansion Therapeutics — by email.

Frequently Asked Questions

Creyon Bio — Delivering RNA breakthroughs. Redefining hope. . Expansion Therapeutics — Bringing transformative therapies to patients with severe RNA-mediated diseases.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Creyon Bio has raised $40.00M while Expansion Therapeutics has raised $142.22M.
Creyon Bio and Expansion Therapeutics operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Creyon Bio with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Creyon Bio on 15 Jun 2026, and Expansion Therapeutics on 13 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes